Picard Medical, Inc. (PMI)
NYSEAMERICAN: PMI · Real-Time Price · USD
9.60
+0.03 (0.31%)
At close: Oct 8, 2025, 4:00 PM EDT
9.63
+0.03 (0.31%)
After-hours: Oct 8, 2025, 7:09 PM EDT
Picard Medical Market Cap
Picard Medical has a market cap or net worth of $707.53 million as of October 8, 2025.
Market Cap
707.53M
Enterprise Value
769.94M
1-Year Change
n/a
Ranking
Category
Stock Price
$9.60
Market Cap Chart
Since the IPO on August 29, 2025, Picard Medical's market cap has increased from $288.22M to $707.53M, an increase of 145.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 705.32M | -4.97% |
| Oct 6, 2025 | 742.17M | 4.57% |
| Oct 3, 2025 | 709.74M | 5.25% |
| Oct 2, 2025 | 674.37M | 3.51% |
| Oct 1, 2025 | 651.52M | 4.00% |
| Sep 30, 2025 | 626.46M | -2.30% |
| Sep 29, 2025 | 641.20M | - |
| Sep 26, 2025 | 641.20M | 5.97% |
| Sep 25, 2025 | 605.09M | 5.66% |
| Sep 24, 2025 | 572.66M | -0.38% |
| Sep 23, 2025 | 574.87M | 4.00% |
| Sep 22, 2025 | 552.76M | -0.40% |
| Sep 19, 2025 | 554.97M | 5.02% |
| Sep 18, 2025 | 528.44M | 19.34% |
| Sep 17, 2025 | 442.80M | -0.26% |
| Sep 16, 2025 | 443.96M | - |
| Sep 15, 2025 | 443.96M | 6.29% |
| Sep 12, 2025 | 417.68M | -17.92% |
| Sep 11, 2025 | 508.86M | 8.02% |
| Sep 10, 2025 | 471.05M | 0.31% |
| Sep 9, 2025 | 469.60M | -2.14% |
| Sep 8, 2025 | 479.89M | 13.85% |
| Sep 5, 2025 | 421.53M | 2.09% |
| Sep 4, 2025 | 412.88M | 8.32% |
| Sep 3, 2025 | 381.18M | 2.92% |
| Sep 2, 2025 | 370.37M | 28.50% |
| Aug 29, 2025 | 288.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |